US Stock MarketDetailed Quotes

AMED Amedisys

Watchlist
  • 92.160
  • +0.230+0.25%
Close Jan 8 16:00 ET
  • 92.000
  • -0.160-0.17%
Pre 05:34 ET
3.02BMarket Cap36.57P/E (TTM)

Amedisys Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Amedisys Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 609.993M--
--2024/Q4-- / 597.274M--
--2024/Q3587.671M / 588.815M--
--2024/Q2591.187M / 581.820M--
--2024/Q1571.414M / 569.252M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 609.993M--
--2024/Q4-- / 597.274M--
--2024/Q3587.671M / 588.815M--
--2024/Q2591.187M / 581.820M--
--2024/Q1571.414M / 569.252M--

Unlock Free Earnings Estimates

Amedisys Earnings Reports

  • Amedisys | 10-Q: Q3 2024 Earnings Report

    Nov 7, 2024 08:03 ET

  • Amedisys | 8-K: AMEDISYS REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS

    Nov 6, 2024 16:32 ET

  • Amedisys | 10-Q: Q2 2024 Earnings Report

    Jul 25, 2024 08:03 ET

  • Amedisys | 8-K: AMEDISYS REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS

    Jul 24, 2024 16:36 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Collegium Pharmaceutical
    COLL
    +14.41%
    eBay
    EBAY
    +9.86%
    Halozyme Therapeutics
    HALO
    +5.02%
    SilverCrest Metals
    SILV
    +4.63%
    Workday
    WDAY
    +2.01%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Jan 7, 2025

    Hold

    • Buy

      0.00%

    • Hold

      100.00%

    • Sell

      0.00%

    Price Target

    No Data